The initial reporter received questionable elecsys ft3 iii and elecsys ft4 iii assay results for one patient tested on a cobas 8000 e 602 module.The serial number was requested but was not provided.It was requested but not provided if the initial results were reported outside the laboratory.Due to the tsh result not matching the clinical status of "graves," the customer performed repeat testing with the patient's sample on the cobas 8000 e 602 module, an abbott architect, and a beckman coulter analyzer.This medwatch is for ft4 assay.Refer to the medwatch with patient identifier (b)(6) for the ft3 assay.
|
The customer's calibration and qc results were requested but not provided.The customer provided the patient's sample for investigation.The investigation confirmed the customer's ft4 and ft3 results.Upon further investigation of the patient sample, an interferent against a component of the reagent was confirmed, ruthenium.This interference is covered in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.Updated medwatch field: d4 - lot number.
|